Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ischemic Central Retinal Vein Occlusion”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Post-approval studies (Phase 4)UnknownNCT02522897
What this trial is testing

Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas

Who this might be right for
Central Retinal Vein Occlusion With Macular Edema
PD. Dr. med. Armin Wolf 60
Post-approval studies (Phase 4)Study completedNCT02478515
What this trial is testing

Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Nagoya City University 27
Not applicableUnknownNCT04075695
What this trial is testing

Ultra-wide-field Fluorescein Angiography in Patients With Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Renmin Hospital of Wuhan University 60
Not applicableLooking for participantsNCT03680794
What this trial is testing

Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies

Who this might be right for
Diabetic RetinopathyRetinal Vein Occlusion
CHU de Reims 120
Testing effectiveness (Phase 2)WithdrawnNCT00727038
What this trial is testing

Lucentis for New Onset Neovascular Glaucoma

Who this might be right for
GlaucomaNew Onset GlaucomaNeovascular Glaucoma+1 more
University of Illinois at Chicago
Not applicableStudy completedNCT02880644
What this trial is testing

Ultra-wide Fluorescein Angiography in Patients With Central Retinal Vein Occlusion Treated by Afilbercept

Who this might be right for
Retinal Vein Occlusion
Centre Hospitalier Intercommunal Creteil 65
Large-scale testing (Phase 3)Study completedNCT00493064
What this trial is testing

To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions

Who this might be right for
Retinal Vein Occlusion
Palo Alto Medical Foundation 63
Large-scale testing (Phase 3)Study completedNCT00000131
What this trial is testing

Central Vein Occlusion Study (CVOS)

Who this might be right for
Retinal Vein OcclusionRetinal Diseases
National Eye Institute (NEI)
Large-scale testing (Phase 3)Study completedNCT01295112
What this trial is testing

Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion

Who this might be right for
Non-Ischemic Central Retinal Vein Occlusion
Texas Retina Associates 68
Not applicableStudy completedNCT05345808
What this trial is testing

Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusions

Who this might be right for
Retinal Vein Occlusion
Al-Azhar University 46
Not applicableStudy completedNCT02898480
What this trial is testing

Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning

Who this might be right for
Retinal Artery OcclusionRetinal Vein Occlusion
University of Aarhus 20
Not applicableStudy completedNCT00804102
What this trial is testing

Transcorneal Electrical Stimulation Therapy for Retinal Disease

Who this might be right for
Retinitis PigmentosaMacula OffPrimary Open Angle Glaucoma+8 more
Okuvision GmbH 80
Large-scale testing (Phase 3)UnknownNCT02947867
What this trial is testing

Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG

Who this might be right for
Ischaemic Central Retinal Vein OcclusionNeovascular Glaucoma
Gene Signal SAS 333
Post-approval studies (Phase 4)Study completedNCT00557232
What this trial is testing

Intraocular Bevacizumab (Avastin) for Rubeosis Iridis

Who this might be right for
GlaucomaRubeosis Iridis
Instituto de Olhos de Goiania 25
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Emerging Indications for Hyperbaric Oxygen Treatment

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Not applicableUnknownNCT04140448
What this trial is testing

Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
Renmin Hospital of Wuhan University 60
Testing effectiveness (Phase 2)UnknownNCT02957760
What this trial is testing

Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.

Who this might be right for
Central Retinal Vein Occlusion, Non-Ischemic
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 30
Post-approval studies (Phase 4)UnknownNCT05282420
What this trial is testing

Ranibizumab Versus Aflibercept for CRVO in Young Patients.

Who this might be right for
Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
South Valley University 40
Not applicableStudy completedNCT01360385
What this trial is testing

Retinal Ischemia in Central Retinal Vein Occlusion, and the Effects of Treatment With Intravitreal Ranibizumab

Who this might be right for
Central Retinal Vein Occlusion
Glostrup University Hospital, Copenhagen 24
Early research (Phase 1)Ended earlyNCT01225146
What this trial is testing

Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)

Who this might be right for
IschemiaRetinal Vein OcclusionPathologic Processes+2 more
David M. Brown, M.D. 8
Next Page